European Approval Authority checks Approval Application for Tenofir Alafenemid (TAF) for the Treatment of chronic Hepatitis B

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2016年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [21] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Lim, Young-Suk
    Chan, Henry Lik Yuen
    Seto, Wai-Kay
    Ning, Qing
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott K.
    Shalimar
    Brunetto, Maurizia R.
    Flaherty, John F.
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward J.
    Hou, Jinlin
    Buti, Maria
    HEPATOLOGY, 2019, 70 : 126A - 127A
  • [22] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Chan, Henry Lik Yuen
    Lim, Young-Suk
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin O.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar
    Brunetto, Maurizia
    Flaherty, John
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    GUT, 2020, 69 : A75 - A76
  • [23] Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies
    Arama, Victoria
    Leblebicioglu, Hakan
    Simon, Krzysztof
    Zarski, Jean Pierre
    Niederau, Claus
    Habersetzer, Francois
    Vermehren, Johannes
    Bludzin, Wieslawa
    Jinga, Mariana
    Ulusoy, Sercan
    Klauck, Isabelle
    Morais, Edith
    Bjork, Stefan
    Lescrauwaet, Benedicte
    Kamar, Driss
    Zeuzem, Stefan
    ANTIVIRAL THERAPY, 2014, 19 (03) : 245 - 257
  • [24] Interferon-α treatment of chronic hepatitis B in childhood:: A consensus advice based on experience in European children
    Jara, P
    Bortolotti, F
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 29 (02): : 163 - 170
  • [25] CHRONIC HEPATITIS B AND C PATIENT MANAGEMENT AND TREATMENT RESTRICTIONS - CURRENT PRACTICE IN SIX EUROPEAN COUNTRIES
    Falla, A.
    Veldhuijzen, I.
    Ahmad, A.
    Levi, M.
    Richardus, J. H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S400 - S400
  • [26] Potential clinical application of RNAi-based therapeutic strategies for treatment of chronic hepatitis B
    ZhaoriGetu
    儿科学（英文）, 2018, 2 (01) : 4 - 5-6-7
  • [27] Potential clinical application of RNAi-based therapeutic strategies for treatment of chronic hepatitis B
    Zhaori, Getu
    PEDIATRIC INVESTIGATION, 2018, 2 (01) : 4 - 7
  • [28] NO DETECTED RESISTANCE TO TENOFOVIR ALAFENAMIDE (TAF) TREATMENT IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB): RESULTS FROM WEEK 24 PRIMARY ENDPOINT ANALYSIS
    Schwarz, Kathleen B.
    Bezerra, Jorge A.
    Liu, Yang
    Han, Dong
    Xu, Simin
    Yazdi, Tahmineh
    May, Lindsey
    Chang, Silvia
    Martin, Ross
    Mo, Hongmei
    Abramov, Frida
    Flaherty, John F.
    Rosenthal, Philip
    Chang, Mei-Hwei
    HEPATOLOGY, 2022, 76 : S255 - S256
  • [29] Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
    Jachs, Mathias
    Sauberer, Raphael
    Stiegler, Alexander
    Dechene, Anton
    Tazreiter, Raphael
    Hartl, Lukas
    Bauer, David
    Balcar, Lorenz
    Strassl, Robert
    Mandorfer, Mattias
    Trauner, Michael
    Munda, Petra
    Ferenci, Peter
    Reiberger, Thomas
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (03) : 293 - 304
  • [30] EFFECTIVENESS OF AND PREDICTORS ASSOCIATED WITH VIROLOGIC RESPONSE TO TENOFOVIR ALAFENAMIDE (TAF) IN NUCLEOSIDE (TIDE) ANALOGUE (NA) TREATMENT NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN CHINA
    Chen, Peng
    Xu, Liang
    Kuai, Wentao
    Wei, Wei
    Liu, Huan
    Zhu, Yu
    HEPATOLOGY, 2021, 74 : 478A - 479A
12345